— Know what they know.
Not Investment Advice

6086.HK

Fangzhou Inc.
1W: -8.7% 1M: -42.6% 3M: -57.4% YTD: -48.7% 1Y: -61.7%
HK$1.32 ($0.17)
-0.04 (-2.94%)
 
HKSE · Consumer Cyclical · Drug Manufacturers - General · HK$1.9B
Smart Money Score
No convergence signal
Key Statistics
Market CapHK$1.9B ($239.8M)
52W Range1.2-6.2
Volume1,460,500
Avg Volume25,581,041
Beta3.24
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEOYuming Zou
Employees488
SectorConsumer Cyclical
IndustryDrug Manufacturers - General
IPO Date2024-07-09
WebsiteJianke.com
Building S, Kehui Jingu
Guangzhou
CN
86 40 0086 5111
About Fangzhou Inc.

Fangzhou Inc. provides online chronic disease management services in China. The company provides services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It offers H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; and healthcare products through online retail pharmacy service platform, as well as operates hospitals and offline pharmacies. The company was founded in 2015 and is based in Guangzhou, China.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms